Table 2 The distribution and frequency of the radiographic findings.
From: Chest X-ray findings monitoring COVID-19 disease course and severity
No. (%) | |
|---|---|
X-ray findings | |
Negative | 82 (23.4) |
Initial negative then become positive | 48 (13.7) |
Positive from start | 220 (62.9) |
Initial X-ray (n = 350) | |
Negative | 130 (37.1) |
Positive | 220 (62.9) |
1st follow-up X-ray (1–4 days) (n = 276) | |
Negative | 40 (14.5) |
Positive | 236 (85.5) |
2nd follow-up X-ray (5–9 days) (n = 167) | |
Negative | 29 (17.4) |
Positive | 138 (82.6) |
3rd follow-up X-ray (10–15 days) (n = 135) | |
Negative | 39 (28.9) |
Positive | 96 (71.1) |
4th follow-up X-ray (> 15 days) (n = 132) | |
Negative | 51 (38.6) |
Positive | 81 (61.4) |
Affected lung | |
Right | 42 (15.7) |
Left | 45 (16.8) |
Both | 181 (67.5) |
Distribution | |
Perihilar | 31(11.6) |
Peripheral | 156 (58.2) |
Neither | 81 (30.2) |
Ground glass appearance | 87 (32.5) |
Consolidation | 218 (81.3) |
Reticular thickening | 107 (39.9) |
Pulmonary nodules | 25 (9.3) |
Pleural effusion | 20 (7.5) |
Predominance | |
Upper zone | 17 (6.4) |
Lower zone | 196 (73.1) |
Non-zonal | 55 (20.5) |
Maximum severity score | |
0 | 82 (23.4) |
1 | 57 (16.2) |
2 | 91 (26.0) |
3 | 38 (10.9) |
4 | 24 (6.9) |
5 | 20 (5.7) |
6 | 16 (4.6) |
7 | 20 (5.7) |
8 | 2 (0.6) |
Time to maximum total severity score | |
Initial X-ray | 113 (42.2) |
1–4 days | 92 (34.3) |
5–9 days | 58 (21.6) |
10–15 days | 5 (1.9) |